Product Name:Potassium 3-ethoxy-3-oxopropanoate

IUPAC Name:potassium 3-ethoxy-3-oxopropanoate

CAS:6148-64-7
Molecular Formula:C5H7KO4
Purity:95%+
Catalog Number:CM254041
Molecular Weight:170.21

Packing Unit Available Stock Price($) Quantity
CM254041-1000g in stock Ǹħ

For R&D use only.

Inquiry Form

   refresh    

Product Details

CAS NO:6148-64-7
Molecular Formula:C5H7KO4
Melting Point:-
Smiles Code:O=C([O-])CC(OCC)=O.[K+]
Density:
Catalog Number:CM254041
Molecular Weight:170.21
Boiling Point:297.3°C at 760 mmHg
MDL No:MFCD00035603
Storage:Keep in a tight container and store at ambient temperature

Category Infos

Aliphatic Chain Compounds
Aliphatic chain compounds include aliphatic compounds and chain compounds containing other elements or groups. Aliphatic hydrocarbons are hydrocarbons with the basic properties of aliphatic compounds. In aliphatic compounds, carbon atoms are arranged in straight chain, branched chain or cyclic, which are respectively called straight chain aliphatic hydrocarbons, branched chain aliphatic hydrocarbons and alicyclic hydrocarbons. Some cyclic hydrocarbons are different in nature from aromatic hydrocarbons, and are very similar to aliphatic hydrocarbons. Such cyclic hydrocarbons are called alicyclic hydrocarbons. In this way, aliphatic hydrocarbons become a general term for all hydrocarbons except aromatic hydrocarbons. Aliphatic hydrocarbons and their derivatives (including halogenated hydrocarbons) and alicyclic hydrocarbons and their derivatives are collectively referred to as aliphatic compounds.

Column Infos

BNC-210
Bionomics Ltd.’s drug candidate, BNC-210 would be advanced into Phase 3 studies in Social Anxiety Disorder (SAD) after the successful End-of-Phase 2 Meeting with the U.S. FDA in September. BNC-210 has a unique action potential that depends on acetylcholine neurotransmission and allosteric modulation of α7 nAChR. It is designed to treat patients with serious central nervous system (CNS) disorders with limited side effects. BNC-210 received Fast-Track designation from the FDA for the acute treatment of SAD.